|1.||Calafat, Antonia M: 3 articles (01/2014 - 02/2010)|
|2.||Lee, Byung Mu: 3 articles (03/2010 - 08/2007)|
|3.||Wang, Shu-Li: 2 articles (01/2015 - 12/2014)|
|4.||Li, Wei: 2 articles (11/2014 - 11/2013)|
|5.||Li, Dan: 2 articles (10/2014 - 01/2014)|
|6.||Zhao, Yan: 2 articles (10/2014 - 01/2014)|
|7.||Chen, Li: 2 articles (10/2014 - 01/2014)|
|8.||Rakkestad, Kirsten E: 2 articles (02/2012 - 02/2010)|
|9.||Paulsen, Ragnhild E: 2 articles (02/2012 - 02/2010)|
|10.||Becher, Rune: 2 articles (02/2012 - 02/2010)|
12/01/2014 - "In contrast, patients with endometriosis or adenomyosis showed a marginally increased level of urinary MEHP only. "
06/01/2010 - "The positive associations for MBP and inverse associations for MEHP in relation to endometriosis and leiomyomata warrant investigation in prospective studies."
06/01/2010 - "Findings for MEHHP and MEOHP agreed with findings for MEHP with respect to endometriosis only. "
12/15/2009 - "Adjusted odds ratio (95% confidence interval) for higher dichotomized MEHP by endometriosis was 1.57 (0.74-3.30). "
10/01/2013 - "We observed a strong inverse association between urinary mono-(2-ethyl-5-hexyl) phthalate (MEHP) concentration and endometriosis risk, particularly when comparing the fourth and first MEHP quartiles (aOR 0.3, 95% CI: 0.1-0.7). "
11/01/2014 - "From a functional standpoint, inhibition of endogenous Mta1 expression along with anti-inflammation treatment in cultured SCs could rescue MEHP-inhibited TIMP2 and subsequently rebalanced MMP2 activity to the control level. "
03/22/2007 - "However, it is suggested that the inflammation in the MEHP groups was primarily mediated by an IgG1-dependent mechanism. "
03/22/2007 - "To address implications for humans, a margin-of-exposure was estimated based on the lack of significant effects on IgE production and inflammation after exposures to 0.03 mg/m(3) MEHP observed in the present study and estimated human exposure levels."
05/01/2015 - "Plasticizer di(2-ethylhexyl) phthalate (DEHP) and its active metabolite MEHP have important immunotoxic effects in mammalian species, including inhibition of cell proliferation, inflammation inhibition, lowering of the antibody response, and apoptosis. "
09/01/1997 - "The proposed mechanism of effect states that mono(2-ethylhexyl) phthalate (MEHP), the primary hydrolysis product of DEHP, mimics the inducing prostaglandins (PG) PGD(2), 9alpha,11betaPGF2, and PGF2alpha, and thromboxanes in the lungs, thereby increasing the risk of inducing inflammation in the airways, which is a characteristic of asthma."
05/01/2012 - "Addition of the MMP2-specific inhibitor SB-3CT inhibited MEHP-enhanced cell invasion and migration, demonstrating that MMP2 plays a functional role in promoting testicular embryonal carcinoma progression in response to MEHP exposure. "
05/01/2012 - "In this study, we show that mono-(2-ethylhexyl) phthalate (MEHP) induces matrix metalloproteinase 2 (MMP2) expression in testicular embryonal carcinoma NT2/D1 cells but has no significant effect on MMP9 expression. "
01/01/2010 - "In this study, we aimed to determine the plasma DEHP and MEHP levels in pubertal gynecomastia cases. "
01/01/2010 - "Plasma DEHP and MEHP levels were found to be statistically significantly higher in the pubertal gynecomastia group compared with the control group (P < .001) (DEHP, 4.66 +/- 1.58 and 3.09 +/- 0.90 microg/mL, respectively [odds ratio: 2.77 (95% confidence interval: 1.48-5.21)]; MEHP, 3.19 +/- 1.41 and 1.37 +/- 0.36 microg/mL [odds ratio: 24.76 (95% confidence interval: 3.5-172.6)]). "
01/01/2010 - "In the pubertal gynecomastia group, no correlation could be determined between plasma DEHP and MEHP levels and any of the hormone levels. "
|1.||Diethylhexyl Phthalate (DEHP)
|2.||phthalic acid (phthalate)
|3.||Matrix Metalloproteinase 2 (Gelatinase A)
|4.||Immunoglobulin E (IgE)
|6.||4-boronic acid benzophenone